|
COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 20,1997 PSA#1786National Cancer Institute, Research Contracts Branch, PCCS, Executive
Plaza South, Room 635, Bethesda, Md 20892 A -- RESEARCH AND DEVELOPMENT -- PHASE 2 CLINICAL TRIAL OF
CHEMOPREVENTIVE AGENTS -- A RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED CLINICAL TRIAL OF A NONSTERIODAL ANTI-INFLAMMATORY
AGENT TO-BE-NAMED AND DFMO COMBINATION AGAINST VARIOUS ENDPOINTS OF
COLORECTAL PATHOBIOLOGY IN A COHORT OF IN POC Theresa H. Shroff CNT
N01-CN-75019 AMT $2,760,852 DTD 021597 TO University of California at
Irvine, 115 Administrative Boulevard, Irvine, California 92717 E-MAIL:
Theresa H. Shroff, shrofft@rec.nci.nih.gov. (0049) Loren Data Corp. http://www.ld.com (SYN# 0359 19970220\A-0003.AWD)
A - Research and Development Index Page
|
|